585 results on '"Campieri, M."'
Search Results
2. P571 Can Crohnʼs colits be cured by surgery?
3. P581 Highly purified eicosapentaenoic acid, as free fatty acid, reduces fecal calprotectin levels and prevents clinical relapse in ulcerative colitis patients: a double-blind, randomized, placebo controlled trial
4. New insights into the brain involvement in patients with Crohn’s disease: a voxel-based morphometry study
5. Medical treatment and management of severe ulcerative colitis
6. Interaction of probiotic Lactobacillus and Bifidobacterium strains with human intestinal epithelial cells: Adhesion properties, competition against enteropathogens and modulation of IL-8 production
7. CT-guided percutaneous pelvic abscess drainage in Crohn’s disease
8. Beclomethasone dipropionate versus mesalazine in distal ulcerative colitis: A multicenter, randomized, double-blind study
9. Local Injection of Infliximab for the Treatment of Perianal Crohn’s Disease
10. Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis
11. The effect of transient intestinal ischemia on inflammatory parameters
12. Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis
13. Risk of permanent stoma in extensive Crohnʼs colitis: the impact of biological drugs
14. Oral beclomethasone dipropionate in patients with mild to moderate ulcerative colitis: A dose-finding study
15. Use of anti-tumour necrosis factor agents in inflammatory bowel disease: European guidelines for 2001–2003
16. New steroids and new salicylates in inflammatory bowel disease: A critical appraisal. (Paper)
17. Distinct proteomic profiles characterise non-erosive from erosive reflux disease
18. Potential role of the cannabinoid receptor CB1 in the pathogenesis of erosive and non-erosive gastro-oesophageal reflux disease
19. Comparison of oral with rectal mesalazine in the treatment of ulcerative proctitis
20. Clinical trial: ulcerative colitis maintenance treatment with 5-ASA: a 1-year, randomized multicentre study comparing MMX® with Asacol®
21. Short-term treatment with infliximab in chronic refractory pouchitis and ileitis
22. Controlled study using wireless capsule endoscopy for the evaluation of the small intestine in chronic refractory pouchitis
23. Oral budesonide in the treatment of chronic refractory pouchitis
24. Review article: aminosalicylates for distal colitis
25. Antibiotic treatment of Crohnʼs disease: results of a multicentre, double blind, randomized, placebo-controlled trial with rifaximin
26. Effects of new fish oil derivative on fatty acid phospholipid-membrane pattern in a group of Crohn's disease patients
27. Mucosal concentrations of interleukin-1β, interleukin-6, interleukin-8, and tumor necrosis factor-α in pelvic ileal pouches
28. Probiotics and barrier function in colitis
29. Microbiology
30. Abstract form for the Irish Journal of Medical Science v workshop on gastroduodenal pathology and Helicobacter pylori July 5th — 7th 1992 — Dublin, Ireland
31. Modulation of human dendritic cell phenotype and function by probiotic bacteria
32. problematic proctitis and distal colitis
33. Scavenger effect of sulfasalazine, 5-aminosalicylic acid, and olsalazine on superoxide radical generation
34. Anti-Saccharomyces cerevisiae antibodies (ASCA) and autoimmune liver diseases
35. Oral beclometasone dipropionate in the treatment of extensive and left-sided active ulcerative colitis: a multicentre randomised study
36. Review article: medical treatment of severe ulcerative colitis
37. Treatment of distal colitis
38. Monitoring activity in ulcerative colitis
39. The management of refractory Crohn's disease
40. Treatment of mild to moderate ulcerative colitis and pouchitis
41. Oral beclometasone dipropionate in the treatment of active ulcerative colitis: a double-blind placebo-controlled study
42. Four-week open-label trial of metronidazole and ciprofloxacin for the treatment of recurrent or refractory pouchitis
43. Activation of signal-transducer and activator of transcription 1 (STAT1) in pouchitis
44. Oral versus combination mesalazine therapy in active ulcerative colitis: a double-blind, double-dummy, randomized multicentre study
45. MCP-3 in inflammatory bowel disease
46. Ultrasonographic findings in Crohnʼs disease
47. Rifaximin systemic absorption in patients with ulcerative colitis
48. Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis
49. Antibiotic combination therapy in patients with chronic, treatment-resistant pouchitis
50. RIFAXIMIN IN PATIENTS WITH MODERATE OR SEVERE ULCERATIVE COLITIS REFRACTORY TO STEROID-TREATMENT: A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.